Sanguinarium

Sanguinarium

SCHEMBL29385229

C[n+]1cc2c3c(ccc2c2ccc4cc5c(cc4c21)OCO5)OCO3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAD Q92934 7/20 1.00
ALDH1A1 P00352 6/20 1.00
MAPT P10636 6/20 1.00
HPGD P15428 6/20 1.00
SMN1; SMN2 Q16637 6/20 1.00
MAPK1 P28482 5/20 1.00
KMT2A Q03164 5/20 1.00
KDM4E B2RXH2 4/20 1.00
MEN1 O00255 4/20 1.00
LMNA P02545 4/20 1.00
ACHE P22303 4/20 1.00
TP53 P04637 3/20 1.00
CYP3A4 P08684 3/20 1.00
ALOX15 P16050 3/20 1.00
ALOX12 P18054 3/20 1.00
HSD17B10 Q99714 3/20 1.00
BCHE P06276 3/20 1.00
RGS17 Q9UGC6 2/20 1.00
RGS12 O14924 2/20 1.00
NPC1 O15118 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sanguinarium SCHEMBL30153784 1.00 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL23524622 1.00 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL30129850 1.00 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL123241 1.00 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL8584009 0.99 BAD (0.97) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL43290 0.99 RAC1 (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL30668087 0.99 RAC1 (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL8937106 0.99 BAD (0.97) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL3222766 0.97 RAC1 (0.97) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL8583232 0.97 RAC1 (0.97) BADALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3585833-B1 EFFICIENT PHOSPHOROUS STABILISERS BASED ON DIPHENYLAMINE AND HETEROCYCLIC DIPHENYLAMINE DERIVATIVES FRAUNHOFER GES FORSCHUNG (DE) 2026-04-01 EP claimed
EP-4674894-A2 COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES Hemoteq AG (DE) 2026-01-07 EP claimed
EP-4663688-A2 CROSSLINKERS Hemoteq AG (DE) 2025-12-17 EP claimed
EP-3060043-B1 PESTICIDAL COMPOSITIONS AND RELATED METHODS CORTEVA AGRISCIENCE LLC (US) 2025-11-26 EP claimed
US-12471599-B2 Agricultural compositions comprising remodeled nitrogen fixing microbes PIVOT BIO, INC. (US) 2025-11-18 US claimed
EP-3578542-B1 COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-11-12 EP claimed
EP-4260682-B1 LIGHTING METHOD FOR PROMOTING ACCUMULATION OF SECONDARY METABOLITES IN CHELIDONIUM MAJUS PLANTS LITHUANIAN RES CENTRE FOR AGRICULTURE AND FORESTRY (LT) 2025-10-29 EP claimed
EP-3578543-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-08-20 EP claimed
EP-3966344-B1 KINASE SCREENING ASSAYS UNIV NEWCASTLE (GB) 2025-06-25 EP claimed
US-20250185667-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES HSBC BANK USA, N.A. 2025-06-12 US claimed
US-20250160275-A1 COMPOUNDS FOR MODIFYING MEIOTIC RECOMBINATION AND METHODS RELATING THERETO THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2025-05-22 US claimed
US-20240389587-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) 2024-11-28 US claimed
EP-4440313-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS Institut national de recherche pour l'agriculture, L'alimentation et l'environnement (INRAE) (FR) 2024-10-09 EP claimed
EP-3403644-B1 PREPARATION FOR ORAL CAVITY LG HOUSEHOLD & HEALTH CARE LTD (KR) 2024-03-06 EP claimed
EP-3360533-B1 PATCH FOR TOOTH ATTACHMENT ABLE TO BE REMOVED BY TOOTH BRUSHING LG HOUSEHOLD & HEALTH CARE LTD (KR) 2023-07-26 EP claimed
WO-2023099609-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) 2023-06-08 WO claimed
EP-4186367-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE) (FR) 2023-05-31 EP claimed
US-20230074763-A1 IDENTIFICATION OF HOST-TARGETING MODULATORS OF BACTERIAL UPTAKE AND ASSAY FOR QUANTIFYING INTRACELLULAR BACTERIA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2023-03-09 US claimed
EP-4093419-A1 SUBSTANCE COMBINATION WITH ISOQUINOLINE ALKALOIDS AND A COCCIDIOSTAT OR COCCIDIOSIS INOCULANT Phytobiotics Futterzusatzstoffe GmbH (DE) 2022-11-30 EP claimed
EP-3137040-B1 ORAL CARE COMPOSITION CONTAINING SILICA AND ZINC CITRATE COLGATE PALMOLIVE CO (US) 2022-08-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250185667-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES MYB, NANS, NANP BAD 4471/4885ALDH1A1 3242/4885MAPT 3664/4885
US-12471599-B2 Agricultural compositions comprising remodeled nitrogen fixing microbes MYB, NANS, NANP BAD 4471/4885ALDH1A1 3242/4885MAPT 3664/4885
US-20240389587-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS XBP1, ERN1, ERN2 BAD 3051/4885ALDH1A1 4442/4885MAPT 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.